BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37488812)

  • 21. Glucocorticoids in systemic lupus erythematosus.
    Mosca M; Tani C; Carli L; Bombardieri S
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S126-9. PubMed ID: 22018198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blunting Autoantigen-induced FOXO3a Protein Phosphorylation and Degradation Is a Novel Pathway of Glucocorticoids for the Treatment of Systemic Lupus Erythematosus.
    Lu M; Xu W; Gao B; Xiong S
    J Biol Chem; 2016 Sep; 291(38):19900-12. PubMed ID: 27481940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial hydroxychloroquine monotherapy in systemic lupus erythematosus: report of three cases.
    Ichikawa K; Kirino Y; Kunishita Y; Kishimoto D; Takase-Minegishi K; Yoshimi R; Nakajima H
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):259-264. PubMed ID: 33533686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of FKBP4 and FKBP5 gene polymorphisms with disease susceptibility, glucocorticoid efficacy, anxiety, depression, and health-related quality of life in systemic lupus erythematosus patients.
    Lou QY; Li Z; Teng Y; Xie QM; Zhang M; Huang SW; Li WF; Chen YF; Pan FM; Xu SQ; Cai J; Liu S; Tao JH; Liu SX; Huang HL; Wang F; Pan HF; Su H; Xu ZW; Hu WB; Zou YF
    Clin Rheumatol; 2021 Jan; 40(1):167-179. PubMed ID: 32557257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticosteroid dependent decrease in the activity of calcineurin in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
    Sipka S; Szucs K; Szántó S; Kovács I; Lakos G; Kiss E; Antal-Szalmás P; Szegedi G; Gergely P
    Ann Rheum Dis; 2001 Apr; 60(4):380-4. PubMed ID: 11247869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to antimalarials and glucocorticoids treatment and its association with self-reported disease activity in systemic lupus erythematosus patients.
    Correa-Rodríguez M; Rueda-Medina B; Callejas-Rubio JL; Ríos-Fernández R; Gil-Gutiérrez R; Ortego-Centeno N
    Lupus; 2023 Jan; 32(1):74-82. PubMed ID: 36346921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus.
    Du J; Li M; Zhang D; Zhu X; Zhang W; Gu W; Feng Y; Zhai X; Ling C
    Arthritis Res Ther; 2009; 11(4):R108. PubMed ID: 19594946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The relationship between mRNA level of glucocorticoid receptor α, heat shock protein 90, protein level of macrophage migration inhibitory factor and glucocorticoid resistance in systemic lupus erythematosus].
    Guan Y; Zhang Y; Fang M; Guan J; Sun X; Zhang J
    Zhonghua Nei Ke Za Zhi; 2015 Nov; 54(11):922-6. PubMed ID: 26759210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
    Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
    Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H
    Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic lupus erythematosus: review of synthetic drugs.
    Tsang-A-Sjoe MW; Bultink IE
    Expert Opin Pharmacother; 2015; 16(18):2793-806. PubMed ID: 26479437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment].
    Tsanian MÉ; Solov'ev SK; Torgashina AV; Aleksandrova EN; Radenska-Lopovok SG; Nikolaeva EV; Khrennikova IaB; Nasonov EL
    Ter Arkh; 2014; 86(5):40-9. PubMed ID: 25026801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of PER2 gene single nucleotide polymorphisms with genetic susceptibility to systemic lupus erythematosus.
    Dan YL; Zhao CN; Mao YM; Wu Q; He YS; Hu YQ; Xiang K; Yang XK; Sam NB; Wu GC; Pan HF
    Lupus; 2021 Apr; 30(5):734-740. PubMed ID: 33497301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic interaction between genes involved in NF-κB signaling pathway in systemic lupus erythematosus.
    Cen H; Zhou M; Leng RX; Wang W; Feng CC; Li BZ; Zhu Y; Yang XK; Yang M; Zhai Y; Zhang M; Hu LF; Li R; Chen GM; Chen H; Pan HF; Li XP; Ye DQ
    Mol Immunol; 2013 Dec; 56(4):643-8. PubMed ID: 23911423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus.
    Zhou XJ; Lu XL; Nath SK; Lv JC; Zhu SN; Yang HZ; Qin LX; Zhao MH; Su Y; Shen N; Li ZG; Zhang H;
    Arthritis Rheum; 2012 Jan; 64(1):222-31. PubMed ID: 21905002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute acalculous cholecystitis in patients with systemic lupus erythematosus: A unique form of disease flare.
    Yang H; Bian S; Xu D; Zhang F; Zhang X
    Lupus; 2017 Sep; 26(10):1101-1105. PubMed ID: 28355987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions Between Genome-Wide Genetic Factors and Smoking Influencing Risk of Systemic Lupus Erythematosus.
    Cui J; Raychaudhuri S; Karlson EW; Speyer C; Malspeis S; Guan H; Sparks JA; Ni H; Liu X; Stevens E; Williams JN; Davenport EE; Knevel R; Costenbader KH
    Arthritis Rheumatol; 2020 Nov; 72(11):1863-1871. PubMed ID: 32969204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics.
    Aljohani R; Gladman DD; Su J; Urowitz MB
    Clin Rheumatol; 2017 Aug; 36(8):1773-1778. PubMed ID: 28589322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of MBL2 gene polymorphisms and systemic lupus erythematosus susceptibility: A meta-analysis.
    Yuan ZC; Xu WD; Lan YY; Wang JM; Wu Q; Zhou J; Huang AF
    Int J Rheum Dis; 2021 Feb; 24(2):147-158. PubMed ID: 33146461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.